ScrutarSign up free

Corteva, Inc. (CTVA)

SEC filings, insider trading & institutional ownership from EDGAR.

NYSEConsumer StaplesFood Products

Corteva, Inc. is a leading global provider of seed and crop protection solutions for the agriculture industry, incorporated in Delaware in March 2018 and headquartered in Indianapolis, Indiana. The company was separated from DowDuPont on June 1, 2019, becoming an independent publicly traded company on the NYSE under ticker "CTVA," and operates through two segments: Seed and Crop Protection. On October 1, 2025, Corteva announced plans to separate these two businesses into standalone, publicly traded companies via a tax-free spin-off.

The Seed segment develops commercial seed combining advanced germplasm and trait technologies, holding leadership positions in North America corn/soybeans, Europe corn/sunflower, and corn markets in Brazil, India, South Africa, and Argentina, marketed through brands like Pioneer®, Brevant®, and technologies such as Enlist E3® soybeans and PowerCore® corn traits; it distributes products via a multi-channel strategy including the unique Pioneer agency model, regional brands, retail, and licensing, sourcing seeds from contracted third-party growers globally. The Crop Protection segment supplies herbicides, insecticides, fungicides, nitrogen management products, and biologicals under brands like Enlist®, ZORVEC™, and ARYLEX®, sourcing raw materials through long-term supplier contracts and contract manufacturing. The company serves customers in approximately 110 countries, with sales seasonally weighted about 60% to the first half of the year (northern hemisphere) and 40% to the second half (southern hemisphere).

As of December 31, 2025, Corteva employed approximately 21,500 people globally, with workforce distribution of 47% North America, 21% Latin America, 20% EMEA, and 12% Asia-Pacific, and maintains a substantial intellectual property portfolio including approximately 5,900 U.S. patents and 10,200 active patents outside the U.S. as of that date. The company competes globally with major players including BASF, Bayer, FMC, Syngenta, and ChemChina, and operates within a heavily regulated environment governed by agencies such as the EPA, USDA, and FDA in the U.S., alongside similar regulatory frameworks internationally, particularly concerning GMOs, gene editing, and crop protection products.

AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.

RevenueFY2025
$17.4B
▲ 2.9%YoY
Net incomeFY2025
$1.09B
▲ 20.6%YoY
Diluted EPSFY2025
$1.60
▲ 23.1%YoY
Gross margin
47.3%
▲ 365 bpsYoY
Insider net6 mo
−110.2K
shares0 sells0 buys
Institutions
45
$34.36B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$5B$10B$15B$20B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Gross profit$8.23B
Diluted EPS$1.60
Gross margin47.3%
Net margin6.3%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
8-KOct 13, 2026EDGAR
8-KOct 7, 2026EDGAR
8-KOct 7, 2026EDGAR
4TITUS BRIANOct 6, 2026EDGAR
4KISSAM LUTHER C IVOct 6, 2026EDGAR
8-KOct 5, 2026EDGAR
8-KOct 2, 2026EDGAR
8-KOct 1, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
KISSAM LUTHER C IVOct 1, 2026J
TITUS BRIANOct 1, 2026J
Johnson David PaulSep 16, 2026Tax withholding
Johnson Jennifer AmySep 15, 2026Tax withholding
Giesselman Janet PlautJul 31, 2026Grant / award

Top holders

13F & 13D/G • latest quarter

All →
HolderStakeFiledValue
BlackRock, Inc.8.1%Aug 7, 2026$4.56B
Vanguard Capital Management6.5%Aug 13, 2026$3.71B
Capital World Investors6.4%Aug 12, 2026$3.64B
FMR LLC6.1%Aug 13, 2026$3.48B
STATE STREET CORPORATION5.7%Sep 22, 2026$3.24B

CTVA's filings are public. The insight is one click away.

Scrutar's AI reads every CTVA filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze CTVA filingsNo credit cardAI reports included on the free plan

Never miss a CTVA filing.

Get an email when CTVA files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Oct 16, 2026Source: SEC EDGAR.